Consensus statement for the prevention of vascular disease.
This consensus statement for the prevention of vascular disease in people over 50 years of age aims to consolidate key messages from a number of evidence based guidelines and studies. It addresses the assessment and principles of management of risk factors for vascular disease, including those developed by Diabetes Australia, Kidney Health Australia, the National Heart Foundation of Australia, and the National Stroke Foundation of Australia. For more detailed information, particularly concerning treatments and levels of evidence to support the recommendations outlined in this statement, refer to the source guidelines and literature (see References).
D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D001315:Australia; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy; D005194:Family Practice / Q000379:methods*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy; D018570:Risk Assessment / Q000379:methods / Q000592:standards*; D012307:Risk Factors; D014652:Vascular Diseases / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*
D001241:Aspirin